Evidence map›Paper›PMID 41946916›Full record

ArticleCommunications chemistry2026

Heparin microarray-based specific interaction assay of marine sulfated polysaccharides with antithrombin Ⅲ.

Fei Wang, Qi Li, Han Zhou, Chanjuan Liu, Guangli Yu, Guoyun Li

Abstract read
In one paragraph

Article in Communications chemistry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Fei Wang *Key Laboratory of Marine Drugs (Ministry of Education), Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Qi Li *Key Laboratory of Marine Drugs (Ministry of Education), Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Han ZhouKey Laboratory of Marine Drugs (Ministry of Education), Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Chanjuan LiuKey Laboratory of Marine Drugs (Ministry of Education), Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China. liuchanjuan@ouc.edu.cn.ORCID http://orcid.org/0009-0000-3370-9030
Guangli YuKey Laboratory of Marine Drugs (Ministry of Education), Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China.
Guoyun LiKey Laboratory of Marine Drugs (Ministry of Education), Shandong Key Laboratory of Glycoscience and Glycotherapeutics, School of Medicine and Pharmacy, Ocean University of China, Qingdao, China. liguoyun@ouc.edu.cn.ORCID http://orcid.org/0000-0002-5529-9391

Funding

National Natural Science Foundation of China (National Science Foundation of China) 31900921;32371338Natural Science Foundation of Shandong Province (Shandong Provincial Natural Science Foundation) ZR2018BH042Taishan Scholar Project of Shandong Province TSQN20210304,TSPD202408073
6 · The paper itself

Abstract

Marine sulfated polysaccharides (SPs) are promising candidates for new anticoagulant drug development, necessitating efficient method to evaluate their anticoagulant activity at the molecular level. In this work, a heparin microarray-based competitive strategy was developed to investigate the specific interactions between SPs and antithrombin Ⅲ (AT). The strategy is based on the principle that SPs competitively bind to the active domain of AT, reducing the signal of AT binding to immobilized heparin on microarrays. Validation was performed using established anticoagulants heparin and enoxaparin as model analytes. After optimizing key experimental conditions, the method successfully determined the IC

Identifiers

PMID41946916
PMCPMC13250064

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.